,business,Sales to assets ratio
0,Novo Nordisk,1.0
1,Roche,0.8
2,Merck & Co.,0.6
3,GlaxoSmithKline,0.5
4,Johnson & Johnson,0.5
5,Biogen,0.5
6,Lilly,0.5
7,Novartis,0.4
8,Gilead,0.4
9,AbbVie,0.4
10,Amgen,0.4
11,AstraZeneca,0.4
12,Mylan,0.4
13,Teva,0.3
14,Bristol-Myers Squibb,0.3
15,Pfizer,0.3
16,Sanofi,0.3
17,Endo,0.3
